PLUR (Pluri Inc. Common Stock) Stock Analysis - News
Pluri Inc. Common Stock (PLUR) is a publicly traded Healthcare sector company. As of May 21, 2026, PLUR trades at $2.60 with a market cap of $33.62M and a P/E ratio of -0.72. PLUR moved +0.00% today. Year to date, PLUR is -13.04%; over the trailing twelve months it is -48.41%. Its 52-week range spans $2.22 to $7.13. Rallies surfaces PLUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in PLUR news today?
Pluri Chairman Invests $2.5M at 30% Premium in Private Placement: Chairman Alejandro Weinstein has committed a further $2.5 million in a private placement at a 30% premium, acquiring 625,000 common shares and warrants for an additional 625,000 shares. The funding bolsters Pluri’s working capital for its 3D cell expansion platform across regenerative medicine, foodtech and agtech.
Manieu Alexandre Weinstein bought 452.70K (~$2.09M) on Apr 28, 2025.
Manieu Alexandre Weinstein bought 523.44K (~$2.41M) on Apr 28, 2025.
Manieu Alexandre Weinstein bought 452.70K (~$2.09M) on Apr 28, 2025.
PLUR Analyst Consensus
PLUR analyst coverage data. Average price target: $0.00.
Common questions about PLUR
What changed in PLUR news today?
Pluri Chairman Invests $2.5M at 30% Premium in Private Placement: Chairman Alejandro Weinstein has committed a further $2.5 million in a private placement at a 30% premium, acquiring 625,000 common shares and warrants for an additional 625,000 shares. The funding bolsters Pluri’s working capital for its 3D cell expansion platform across regenerative medicine, foodtech and agtech.
Does Rallies summarize PLUR news?
Yes. Rallies summarizes PLUR news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is PLUR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PLUR. It does not provide personalized investment advice.
